News
11h
Zacks Investment Research on MSNBeat the Market the Zacks Way: Humacyte, Starbucks, Oracle in FocusLast Thursday, the three most widely followed benchmark indexes closed a third straight winning week. The Dow Jones ...
1h
Zacks Investment Research on MSNBP (BP) Registers a Bigger Fall Than the Market: Important Facts to NoteBP (BP) ended the recent trading session at $30.25, demonstrating a -2.2% change from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of 0.79%. Elsewhere ...
2h
Zacks.com on MSNWhy the Market Dipped But Grab Holdings Limited (GRAB) Gained TodayIn the most recent trading session, Grab Holdings Limited (GRAB) closed at $4.95, indicating a +1.64% shift from the previous trading day.
2h
Zacks.com on MSNHere's Why CRISPR Therapeutics AG (CRSP) Fell More Than Broader MarketThe latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $51.19, representing a -1.88% change from its previous close.
High R&D Expenses & Rising Debt Levels Ail Toyota (TM) Per the Zacks analyst, high R&D expenses on advanced technologies and alternative fuels are likely to limit Toyota's near-term margins. Rising ...
Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months.
(AGAE) on Monday reported a loss of $4.8 million in its first quarter. The New York-based company said it had a loss of 11 cents ...
CZOVX - Zacks All-Cap Core Institutional - Review the CZOVX stock price, growth, performance, sustainability and more to help you make the best investments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results